aluates Reports

$ 0.0

Automative

Global Neuromodulation and Neurostimulation Pain Management Devices Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-0L17453

BUY CHAPTERS

Global Neuromodulation and Neurostimulation Pain Management Devices Market Research Report 2024

Code: QYRE-Auto-0L17453

Report

May 2024

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medtronic Inc

Boston Scientific Corporation

Pfizer Inc. (Hospira Inc.)

Stryker Corporation

Abbott Laboratories

B Braun Melsungen AG

Baxter International Inc

Johnson & Johnson (Codman And Shurtleff, Inc.)

Kimberly-Clark Corporation (Baylis Medical)

Colfax Corporation (Djo Global Llc)

Neuromodulation and Neurostimulation Pain Management Devices Market Size

The global Neuromodulation and Neurostimulation Pain Management Devices market was valued at US$ 2116 million in 2023 and is anticipated to reach US$ 3293 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Neuromodulation and Neurostimulation Pain Management Devices Market

Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.

Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.

This report aims to provide a comprehensive presentation of the global market for Neuromodulation and Neurostimulation Pain Management Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuromodulation and Neurostimulation Pain Management Devices.

The Neuromodulation and Neurostimulation Pain Management Devices market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuromodulation and Neurostimulation Pain Management Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuromodulation and Neurostimulation Pain Management Devices companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neuromodulation and Neurostimulation Pain Management Devices Market Report

Report Metric	Details
Report Name	Neuromodulation and Neurostimulation Pain Management Devices Market
Accounted market size in 2023	US$ 2116 million
Forecasted market size in 2030	US$ 3293 million
CAGR	6.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Spinal Cord Stimulators Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Segment by Application	Neuropathic Pain Cancer Pain Facial & Migraine Pain Musculoskeletal Pain Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic Plc, Boston Scientific Corporation, Pfizer Inc. (Hospira Inc.), Johnson & Johnson (Codman And Shurtleff, Inc.), Stryker Corporation, Kimberly-Clark Corporation (Baylis Medical), Colfax Corporation (Djo Global Llc), Abbott Laboratories, B Braun Melsungen Ag, Baxter International Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuromodulation and Neurostimulation Pain Management Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neuromodulation and Neurostimulation Pain Management Devices Market growing?

Ans: The Neuromodulation and Neurostimulation Pain Management Devices Market witnessing a CAGR of 6.4% during the forecast period 2024-2030.

What is the Neuromodulation and Neurostimulation Pain Management Devices Market size in 2030?

Ans: The Neuromodulation and Neurostimulation Pain Management Devices Market size in 2030 will be US$ 3293 million.

Who are the main players in the Neuromodulation and Neurostimulation Pain Management Devices Market report?

Ans: The main players in the Neuromodulation and Neurostimulation Pain Management Devices Market are Medtronic Plc, Boston Scientific Corporation, Pfizer Inc. (Hospira Inc.), Johnson & Johnson (Codman And Shurtleff, Inc.), Stryker Corporation, Kimberly-Clark Corporation (Baylis Medical), Colfax Corporation (Djo Global Llc), Abbott Laboratories, B Braun Melsungen Ag, Baxter International Inc.

What are the Application segmentation covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report?

Ans: The Applications covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report are Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Others

What are the Type segmentation covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report?

Ans: The Types covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report are Spinal Cord Stimulators, Transcutaneous Electrical Nerve Stimulation (TENS) Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Spinal Cord Stimulators

1.2.3 Transcutaneous Electrical Nerve Stimulation (TENS) Devices

1.3 Market by Application

1.3.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Neuropathic Pain

1.3.3 Cancer Pain

1.3.4 Facial & Migraine Pain

1.3.5 Musculoskeletal Pain

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Perspective (2019-2030)

2.2 Global Neuromodulation and Neurostimulation Pain Management Devices Growth Trends by Region

2.2.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Neuromodulation and Neurostimulation Pain Management Devices Historic Market Size by Region (2019-2024)

2.2.3 Neuromodulation and Neurostimulation Pain Management Devices Forecasted Market Size by Region (2025-2030)

2.3 Neuromodulation and Neurostimulation Pain Management Devices Market Dynamics

2.3.1 Neuromodulation and Neurostimulation Pain Management Devices Industry Trends

2.3.2 Neuromodulation and Neurostimulation Pain Management Devices Market Drivers

2.3.3 Neuromodulation and Neurostimulation Pain Management Devices Market Challenges

2.3.4 Neuromodulation and Neurostimulation Pain Management Devices Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neuromodulation and Neurostimulation Pain Management Devices Players by Revenue

3.1.1 Global Top Neuromodulation and Neurostimulation Pain Management Devices Players by Revenue (2019-2024)

3.1.2 Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Players (2019-2024)

3.2 Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neuromodulation and Neurostimulation Pain Management Devices Revenue

3.4 Global Neuromodulation and Neurostimulation Pain Management Devices Market Concentration Ratio

3.4.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuromodulation and Neurostimulation Pain Management Devices Revenue in 2023

3.5 Global Key Players of Neuromodulation and Neurostimulation Pain Management Devices Head office and Area Served

3.6 Global Key Players of Neuromodulation and Neurostimulation Pain Management Devices, Product and Application

3.7 Global Key Players of Neuromodulation and Neurostimulation Pain Management Devices, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuromodulation and Neurostimulation Pain Management Devices Breakdown Data by Type

4.1 Global Neuromodulation and Neurostimulation Pain Management Devices Historic Market Size by Type (2019-2024)

4.2 Global Neuromodulation and Neurostimulation Pain Management Devices Forecasted Market Size by Type (2025-2030)

5 Neuromodulation and Neurostimulation Pain Management Devices Breakdown Data by Application

5.1 Global Neuromodulation and Neurostimulation Pain Management Devices Historic Market Size by Application (2019-2024)

5.2 Global Neuromodulation and Neurostimulation Pain Management Devices Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size (2019-2030)

6.2 North America Neuromodulation and Neurostimulation Pain Management Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024)

6.4 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size (2019-2030)

7.2 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024)

7.4 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size (2019-2030)

8.2 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region (2019-2024)

8.4 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Size (2019-2030)

9.2 Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024)

9.4 Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size (2019-2030)

10.2 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024)

10.4 Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medtronic Plc

11.1.1 Medtronic Plc Company Details

11.1.2 Medtronic Plc Business Overview

11.1.3 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.1.4 Medtronic Plc Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.1.5 Medtronic Plc Recent Development

11.2 Boston Scientific Corporation

11.2.1 Boston Scientific Corporation Company Details

11.2.2 Boston Scientific Corporation Business Overview

11.2.3 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.2.4 Boston Scientific Corporation Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.2.5 Boston Scientific Corporation Recent Development

11.3 Pfizer Inc. (Hospira Inc.)

11.3.1 Pfizer Inc. (Hospira Inc.) Company Details

11.3.2 Pfizer Inc. (Hospira Inc.) Business Overview

11.3.3 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.3.4 Pfizer Inc. (Hospira Inc.) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.3.5 Pfizer Inc. (Hospira Inc.) Recent Development

11.4 Johnson & Johnson (Codman And Shurtleff, Inc.)

11.4.1 Johnson & Johnson (Codman And Shurtleff, Inc.) Company Details

11.4.2 Johnson & Johnson (Codman And Shurtleff, Inc.) Business Overview

11.4.3 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.4.4 Johnson & Johnson (Codman And Shurtleff, Inc.) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.4.5 Johnson & Johnson (Codman And Shurtleff, Inc.) Recent Development

11.5 Stryker Corporation

11.5.1 Stryker Corporation Company Details

11.5.2 Stryker Corporation Business Overview

11.5.3 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.5.4 Stryker Corporation Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.5.5 Stryker Corporation Recent Development

11.6 Kimberly-Clark Corporation (Baylis Medical)

11.6.1 Kimberly-Clark Corporation (Baylis Medical) Company Details

11.6.2 Kimberly-Clark Corporation (Baylis Medical) Business Overview

11.6.3 Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.6.4 Kimberly-Clark Corporation (Baylis Medical) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.6.5 Kimberly-Clark Corporation (Baylis Medical) Recent Development

11.7 Colfax Corporation (Djo Global Llc)

11.7.1 Colfax Corporation (Djo Global Llc) Company Details

11.7.2 Colfax Corporation (Djo Global Llc) Business Overview

11.7.3 Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.7.4 Colfax Corporation (Djo Global Llc) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.7.5 Colfax Corporation (Djo Global Llc) Recent Development

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Details

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.8.4 Abbott Laboratories Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.8.5 Abbott Laboratories Recent Development

11.9 B Braun Melsungen Ag

11.9.1 B Braun Melsungen Ag Company Details

11.9.2 B Braun Melsungen Ag Business Overview

11.9.3 B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.9.4 B Braun Melsungen Ag Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.9.5 B Braun Melsungen Ag Recent Development

11.10 Baxter International Inc.

11.10.1 Baxter International Inc. Company Details

11.10.2 Baxter International Inc. Business Overview

11.10.3 Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Introduction

11.10.4 Baxter International Inc. Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

11.10.5 Baxter International Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Boston Scientific Corporation

Pfizer Inc. (Hospira Inc.)

Stryker Corporation

Abbott Laboratories

B Braun Melsungen AG

Baxter International Inc

Johnson & Johnson (Codman And Shurtleff, Inc.)

Kimberly-Clark Corporation (Baylis Medical)

Colfax Corporation (Djo Global Llc)

List of Tables

Table 1. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Spinal Cord Stimulators

Table 3. Key Players of Transcutaneous Electrical Nerve Stimulation (TENS) Devices

Table 4. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Region (2019-2024)

Table 8. Global Neuromodulation and Neurostimulation Pain Management Devices Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Region (2025-2030)

Table 10. Neuromodulation and Neurostimulation Pain Management Devices Market Trends

Table 11. Neuromodulation and Neurostimulation Pain Management Devices Market Drivers

Table 12. Neuromodulation and Neurostimulation Pain Management Devices Market Challenges

Table 13. Neuromodulation and Neurostimulation Pain Management Devices Market Restraints

Table 14. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Players (2019-2024)

Table 16. Global Top Neuromodulation and Neurostimulation Pain Management Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation and Neurostimulation Pain Management Devices as of 2023)

Table 17. Ranking of Global Top Neuromodulation and Neurostimulation Pain Management Devices Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Neuromodulation and Neurostimulation Pain Management Devices Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Neuromodulation and Neurostimulation Pain Management Devices, Headquarters and Area Served

Table 20. Global Key Players of Neuromodulation and Neurostimulation Pain Management Devices, Product and Application

Table 21. Global Key Players of Neuromodulation and Neurostimulation Pain Management Devices, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Type (2019-2024)

Table 25. Global Neuromodulation and Neurostimulation Pain Management Devices Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Type (2025-2030)

Table 27. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Application (2019-2024)

Table 29. Global Neuromodulation and Neurostimulation Pain Management Devices Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Application (2025-2030)

Table 31. North America Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country (2025-2030) & (US$ Million)

Table 46. Medtronic Plc Company Details

Table 47. Medtronic Plc Business Overview

Table 48. Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Product

Table 49. Medtronic Plc Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 50. Medtronic Plc Recent Development

Table 51. Boston Scientific Corporation Company Details

Table 52. Boston Scientific Corporation Business Overview

Table 53. Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Product

Table 54. Boston Scientific Corporation Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 55. Boston Scientific Corporation Recent Development

Table 56. Pfizer Inc. (Hospira Inc.) Company Details

Table 57. Pfizer Inc. (Hospira Inc.) Business Overview

Table 58. Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Product

Table 59. Pfizer Inc. (Hospira Inc.) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 60. Pfizer Inc. (Hospira Inc.) Recent Development

Table 61. Johnson & Johnson (Codman And Shurtleff, Inc.) Company Details

Table 62. Johnson & Johnson (Codman And Shurtleff, Inc.) Business Overview

Table 63. Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Product

Table 64. Johnson & Johnson (Codman And Shurtleff, Inc.) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 65. Johnson & Johnson (Codman And Shurtleff, Inc.) Recent Development

Table 66. Stryker Corporation Company Details

Table 67. Stryker Corporation Business Overview

Table 68. Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Product

Table 69. Stryker Corporation Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 70. Stryker Corporation Recent Development

Table 71. Kimberly-Clark Corporation (Baylis Medical) Company Details

Table 72. Kimberly-Clark Corporation (Baylis Medical) Business Overview

Table 73. Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Product

Table 74. Kimberly-Clark Corporation (Baylis Medical) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 75. Kimberly-Clark Corporation (Baylis Medical) Recent Development

Table 76. Colfax Corporation (Djo Global Llc) Company Details

Table 77. Colfax Corporation (Djo Global Llc) Business Overview

Table 78. Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Product

Table 79. Colfax Corporation (Djo Global Llc) Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 80. Colfax Corporation (Djo Global Llc) Recent Development

Table 81. Abbott Laboratories Company Details

Table 82. Abbott Laboratories Business Overview

Table 83. Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Product

Table 84. Abbott Laboratories Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 85. Abbott Laboratories Recent Development

Table 86. B Braun Melsungen Ag Company Details

Table 87. B Braun Melsungen Ag Business Overview

Table 88. B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Product

Table 89. B Braun Melsungen Ag Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 90. B Braun Melsungen Ag Recent Development

Table 91. Baxter International Inc. Company Details

Table 92. Baxter International Inc. Business Overview

Table 93. Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Product

Table 94. Baxter International Inc. Revenue in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024) & (US$ Million)

Table 95. Baxter International Inc. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Neuromodulation and Neurostimulation Pain Management Devices Picture

Figure 2. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Type: 2023 VS 2030

Figure 4. Spinal Cord Stimulators Features

Figure 5. Transcutaneous Electrical Nerve Stimulation (TENS) Devices Features

Figure 6. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Application: 2023 VS 2030

Figure 8. Neuropathic Pain Case Studies

Figure 9. Cancer Pain Case Studies

Figure 10. Facial & Migraine Pain Case Studies

Figure 11. Musculoskeletal Pain Case Studies

Figure 12. Others Case Studies

Figure 13. Neuromodulation and Neurostimulation Pain Management Devices Report Years Considered

Figure 14. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Region: 2023 VS 2030

Figure 17. Global Neuromodulation and Neurostimulation Pain Management Devices Market Share by Players in 2023

Figure 18. Global Top Neuromodulation and Neurostimulation Pain Management Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation and Neurostimulation Pain Management Devices as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Neuromodulation and Neurostimulation Pain Management Devices Revenue in 2023

Figure 20. North America Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Neuromodulation and Neurostimulation Pain Management Devices Market Share by Country (2019-2030)

Figure 22. United States Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Neuromodulation and Neurostimulation Pain Management Devices Market Share by Country (2019-2030)

Figure 26. Germany Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Share by Region (2019-2030)

Figure 34. China Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Neuromodulation and Neurostimulation Pain Management Devices Market Share by Country (2019-2030)

Figure 42. Mexico Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Neuromodulation and Neurostimulation Pain Management Devices Market Share by Country (2019-2030)

Figure 46. Turkey Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Neuromodulation and Neurostimulation Pain Management Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Medtronic Plc Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 50. Boston Scientific Corporation Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 51. Pfizer Inc. (Hospira Inc.) Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 52. Johnson & Johnson (Codman And Shurtleff, Inc.) Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 53. Stryker Corporation Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 54. Kimberly-Clark Corporation (Baylis Medical) Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 55. Colfax Corporation (Djo Global Llc) Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 56. Abbott Laboratories Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 57. B Braun Melsungen Ag Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 58. Baxter International Inc. Revenue Growth Rate in Neuromodulation and Neurostimulation Pain Management Devices Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.